Resources

Vignette Preloaded Monoka (LacriJet) and congenital nasolacrimal duct obstruction: Initial results

Preloaded Monoka (LacriJet) and congenital nasolacrimal duct obstruction: Initial results Download

February 5, 2024 - 921.42 KB - pdf

Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results

FCI is excited to share the results of a recent study conducted by Bruno Fayet, MD (Paris, France), Jean-Marc Ruban, MD (Lyon, France) and William Katowitz, MD (Philadelphia, USA) on LacriJet®.

This article was published last May, in the ‘French Journal of Ophthalmology’ and highlights the performance of LacriJet® for the management of congenital nasolacrimal duct obstruction (CNLDO).

Vignette Self-Retaining Bicanaliculus Intubation Set – SRS II

Self-Retaining Bicanaliculus Intubation Set – SRS II Download

March 31, 2025 - 739.73 KB - pdf

Self-retaining bicanalicular intubation

Ophtacath® brochure Download

February 28, 2024 - 541.37 KB - pdf

Lacrimal duct balloon catheter kit

Masterka® brochure Download

September 23, 2026 - 743.00 KB - pdf

Unique combination of a punctum plug with a preloaded lacrimal duct stent

FCI Nunchaku® brochure Download

October 29, 2024 - 1.12 MB - pdf

Self-retaining bicanalicular nasolacrimal intubation

StopLoss Jones Tubes brochure Download

June 20, 2024 - 664.71 KB - pdf

Vignette MORCHER® EyeJet® Capsular Tension Rings (CTRs)

MORCHER® EyeJet® Capsular Tension Rings (CTRs) Download

February 5, 2024 - 942.34 KB - pdf

FCI Ophthalmics offers the widest range of options of MORCHER® EyeJet® Capsular Tension Rings (CTRs) for your patients.

LacriJet® brochure Download

June 20, 2024 - 1.27 MB - pdf

LacriJet® is FCI latest and exclusive preloaded and self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Ritleng®+ brochure Download

June 20, 2024 - 863.87 KB - pdf

Ritleng®+ is FCI’s latest autostable bicanalicular nasolacrimal intubation indicated for epiphora, canalicular pathologies, congenital lacrimal duct obstruction and dacryocystorhinostomy (DCR).

FCI Oculoplastics Catalog Download

August 7, 2024 - 13.12 MB - pdf

Since its inception in 1984, the ability to understand, anticipate and respond to the oculoplastic research has resulted in FCI’s strong portfolio of globally recognized products. FCI offers innovative solutions essential in the treatment of dry eye, lacrimal, eyelid, and orbit indications.

Our websites

Questions about our products?